Vyne Therapeutics Inc. (VYNE)
Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
28. 56
0
0%
$
19.07M Market Cap
- P/E Ratio
- Div Yield
93,256 Volume
-1 Eps
$ 28.56
Previous Close 
Want to track VYNE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vyne Therapeutics Inc. (VYNE) Statistics
Valuation metrics
Market Cap 19.07M
Enterprise value 19.05M
Trailing P/E (ttm) -0.04
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 19.97
Price/Book (mrq) 43.99
Enterprise Value/Revenue 19.94
Enterprise Value/EBITDA -0.42
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 39.38K
Average volume (90 days) 72.35K
Price summary
52-Week low 14.03
52-Week high 74.47
Beta -
50-Day moving average 36.76
200-Day moving average 5.55
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 20.12
Trailing annual dividend yield 0.7045%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 23 Jul 2026
Ex-Dividend Date 22 Jul 2026
Last split factor 1:50
Last split Date 27 Jul 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -44.17%
Operating margin -48.77%
Operational effectiveness
Return on assets -1,398.71%
Return on equity -2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 22.33
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -986.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.68
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 12.53%
Book value per share (mrq) 0.65
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
